tradmap

GRI Earnings GRI Bio, Inc.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Annual results

Diluted EPS (annual)
-$5018 -$2509 $0 2020 2021 2022 2023 2024 2025
EPS
Revenue (annual)
$0 $50000 $100000 2020 2021 2022 2023 2024 2025
Revenue
Net income (annual)
-$13M -$7M $0 2020 2021 2022 2023 2024 2025
Net income

Quarterly results

Diluted EPS (quarterly)
-$449 -$225 $0 Q3 '22 Q2 '23 Q1 '24 Q3 '24 Q2 '25 Q1 '26
EPS
Net income (quarterly)
-$3M -$2M $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Net income
Return on equity (quarterly)
-774% -387% 0% Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
ROE

Reported EPS history

1–25 of 25
Q2 20262026-06-30-2.392026-08-1410-Q
Q1 20262026-03-31-1.612026-05-1310-Q
FY 20252025-12-31-121.802026-01-3010-K
Q3 20252025-09-30-5.192025-11-1410-Q
Q2 20262025-06-30-121.362026-08-1410-Q
Q1 20262025-03-31-162.302026-05-1310-Q
FY 20252024-12-31-1545.552026-01-3010-K
Q3 20252024-09-30-77.552025-11-1410-Q
Q2 20252024-06-30-150.322025-08-1410-Q
Q1 20252024-03-31-101.052025-05-1510-Q
FY 20242023-12-31-5018.092025-03-1410-K
Q3 20242023-09-30-449.342024-11-1410-Q
Q2 20242023-06-30-433.142024-08-1410-Q
Q1 20242023-03-31-15.042024-05-1010-Q
FY 20232022-12-31-24.952024-03-2810-K
Q3 20232022-09-30-1.062023-11-1410-Q
Q2 20232022-06-30-0.702023-08-1410-Q
Q1 20232022-03-31-11.622023-05-1510-Q
FY 20222021-12-31-1.422023-02-2410-K
Q3 20222021-09-30-0.962022-11-0310-Q
Q2 20222021-06-30-0.792022-07-2810-Q
Q1 20222021-03-31-0.462022-05-0910-Q
FY 20212020-12-31-1.072022-02-1410-K
Q3 20212020-09-30-0.742021-11-1210-Q
Q2 20212020-06-30-0.512021-08-1010-Q

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.